Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13195-020-00741-z
PubMed Identifier: 33422142
Publication URI: http://europepmc.org/abstract/MED/33422142
Type: Journal Article/Review
Volume: 13
Parent Publication: Alzheimer's research & therapy
Issue: 1